Latest Financials News

Paradigm Biopharmaceuticals has upsized a $14 million placement and launched a $2 million SPP, boosting its cash runway to around $45 million. This capital injection supports the ongoing Phase 3 trial for knee osteoarthritis, with interim results expected in Q3 2026.

Flynn Gold has reported standout assay results from its Tasmanian projects, including exceptional silver-lead-zinc grades at Silver King and significant tungsten-gold mineralisation at Firetower and Warrentinna, underpinning a ramp-up in drilling and regional exploration.

Atomos has finalized its acquisition of Flanders Scientific for $2.35 million cash plus shares, funded by a new $10 million finance facility from Commonwealth Bank. The deal broadens Atomos’ professional video monitoring reach and is expected to add $1 million EBITDA before growth.

Viking Mines has advanced its Linka Tungsten Project by completing a conceptual process flowsheet that incorporates recent metallurgical results and enables future processing upgrades. Preliminary engineering and cost evaluations are underway ahead of planned drilling in the June quarter.

Babylon Pump & Power’s shares remain suspended from ASX trading as the company delays disclosure of a material transaction and capital raising, prolonging market uncertainty beyond the initial deadline.

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.

Nido Education has expanded its footprint with a $9.1 million acquisition of four child care services, adding 348 places and an estimated $1.9 million annualised EBITDA. The company is also actively pursuing further acquisitions beyond its incubation pipeline amid sector demand challenges.

Marvel Gold has completed an extensive drone magnetic survey at its Hanang Gold Project in Tanzania, revealing new mineralisation corridors and preparing to launch its first drilling campaign. Meanwhile, the company is exiting Mali due to regulatory hurdles, progressing the sale of its Yanfolila project.

Albright Metals delivers strong high-grade gold results from its Golden Pike Project in Canada while boosting its balance sheet through a $1.8 million tenement sale to Catalyst Metals, sharpening its focus on high-impact assets.

Diamond Infraco 1 Pty Ltd, backed by IFM Global Infrastructure Fund, has tabled an all-cash takeover offer for the remaining Atlas Arteria securities at A$4.75, rising to A$5.10 if a 45% stake is secured. The bid comes amid concerns over Atlas Arteria’s recent strategic pivot and operational underperformance.

AML3D has maintained a steady $2.2 million quarterly revenue run rate and secured $12.5 million in new orders during 3Q26, pushing its total orders for FY2026 to $29 million. The company is aggressively expanding its US manufacturing footprint and making initial inroads into UK and European defence markets.

IperionX has transitioned its Virginia titanium operations to continuous 24/7 production, ramping proprietary HAMR™ titanium powder output to 4.2 metric tons in March and targeting 200 tons per annum by the end of 2026. Alongside manufacturing capacity expansions and strong U.S. Department of War backing, the company advances its critical minerals project in Tennessee.